Hiring in the Asia-Pacific pharma industry drop by 4% in Q2 2023

MEEFRO July 28, 2023

0 124,533 1 minute read

Notably, Management Occupations jobs accounted for a 23% share of the Asia-Pacific pharma industry’s total new job postings in Q2 2023, drop 14% over the prior quarter.

Management Occupations drive pharma hiring activity

Management Occupations, with a share of 23% new job postings, was the occupation with the greatest hiring activity in the Asia-Pacific pharma industry in Q2 2023 , ahead of Computer and Mathematical Occupations with an 11% share of new job postings.

The other prominent roles included Healthcare Practitioners and Technical Occupations with a 7% share in Q2 2023, Business and Financial Operations Occupations with a 6% share and Life, Physical, and Social Science Occupations with a 6% share of new job postings.

Top five companies accounted for 43% of hiring activity

Syngene International posted 1,873 jobs in Q2 2023 and registered a decline of 69% over the previous quarter, followed by Novartis with 1,814 jobs and a 74% growth. AstraZeneca, with 1,479 jobs, and Pfizer, with 1,446 jobs, recorded a 118% rise and a 69% rise, respectively, while Biocon recorded a 48% decline with a 1,387 new job postings during Q2 2023.

Regional analysis of hiring in the Asia-Pacific pharma industry, Q2 2023

India held the leading share of the Asia-Pacific pharma hiring activity with a 49.83% share, a 23% decrease over Q1 2023. China was next with 26.76%, four-percentage-point up over the previous quarter.

For further understanding of GlobalData’s Pharmaceutical Drugs Development Annual Review, Sales and Forecast, Key Trends and Competitive Analysis, buy the report here.

This content was updated on 24 July 2023